ASH 2017 Highlights: CAR-T Competition, Myeloma, Hemophilia & More
Xconomy
DECEMBER 11, 2017
For now, we’ve chosen updates from three disease areas to highlight, plus the more notable market movements. Non-Hodgkin Lymphoma The first competition in the CAR-T field will be in adult non-Hodgkin lymphoma. The annual American Society of Hematology meeting is nearly over. Note: Ben Fidler co-authored this report.]
Let's personalize your content